As Bob Iger prepares for his second departure, the Disney CEO outlines a forward-looking mandate for his successor during an earnings call, emphasizing evolution in a dynamic media landscape.
JPMorgan raises its price target for Celsius Holdings (CELH) to $77, citing upside potential from its deepening PepsiCo partnership and the expanding distribution of its Alani Nu brand ahead of Q4 earnings.
Despite posting blockbuster profits, Microsoft shares plunged 10% after its latest earnings, erasing hundreds of billions in market value. We examine whether Wall Street's reaction to cloud growth and AI spending fears is an overreaction or a prudent pause.
Amphenol Corporation (NYSE: APH), a key player in electronic connectors, received concurrent price target increases from Seaport Research and Citi. While analysts highlight growth potential, the stock's post-earnings dip underscores a cautious market stance toward the company's traditionally conservative guidance.
Goldman Sachs Group (GS) has approved a significant dividend increase and projects a robust earnings outlook for Corporate America, fueling debate over whether its strong share price momentum has outpaced its fundamental valuation.
Insurance brokerage giant Brown & Brown sees a key price target cut to $81 following its fourth-quarter earnings, which revealed robust fee growth but concerns over slowing organic revenue expansion.
Despite posting impressive revenue and subscriber growth in 2025, Netflix faces a critical headwind: its share of viewer engagement is growing at a fraction of the overall streaming market's pace, signaling intensified competition for attention.
Shares of Empire State Realty Trust (ESRT) are trading at $6.63, presenting investors with a conundrum: a narrative suggesting undervaluation clashes with a premium price-to-earnings multiple. We examine the divergence and what it means for the iconic property owner.
While low-volatility stocks offer a haven during market turmoil, their defensive nature can become a liability in bull markets, potentially causing investors to miss out on significant gains. We examine three such stocks and the risks they currently pose.
The private equity giant announced a dividend increase to $1.49 per share, pushing its yield above the industry average. While future earnings projections are robust, analysts flag concerns over the current payout ratio and the firm's mixed dividend history.
CECO Environmental Corp. (NASDAQ: CECO) has surged in recent months, nearing its yearly high. With the mid-cap clean tech firm now trading near fair value, we analyze whether investors have missed the bargain window or if strategic entry points remain.
While the online marketplace sector posted robust Q3 earnings, investor sentiment remains tepid. Shutterstock's strategic embrace of generative AI and solid financials were overshadowed by a broader sell-off, raising questions about valuation in a shifting digital landscape.
The third-quarter earnings season revealed a stark divergence in performance among leading healthcare technology providers. While Omnicell impressed with strong results and a soaring stock, peers like Evolent Health and Astrana Health faced significant market headwinds despite revenue beats.
As major U.S. banks wrap up their fourth-quarter earnings, a clear divergence emerges. While PNC and Bank of America post strong results, Citigroup and JPMorgan Chase face headwinds. Truist Financial charts a middle course, meeting revenue expectations as the sector navigates a complex economic landscape.
While Italtile's stock saw an 11% bump last month, a look at the past five years reveals a sobering picture for long-term investors, with total shareholder returns deep in negative territory even as company earnings grew.
Hospitality tech provider Agilysys saw its stock price drop sharply post-earnings, even as Q4 revenue topped estimates. Higher development costs squeezed profits, though CEO highlighted strong subscription growth in key segments. Analysts are now scrutinizing the pace of major rollouts and efficiency gains.
Meta Platforms' shares soared following a robust Q4 earnings beat and aggressive AI investment plans. While core advertising thrives, the company's massive capital expenditure hike raises questions about long-term payoff and competitive positioning.
TransDigm Group's recent acquisitions of Stellant Systems and Jet Parts Engineering, totaling over $3 billion, have analysts debating whether the moves solidify its lucrative aftermarket strategy or stretch its leveraged balance sheet too thin ahead of a critical earnings season.
Boston Scientific's latest earnings beat and raised guidance, fueled by strong demand for its electrophysiology devices, signal a strategic shift. The company is navigating tariff pressures while expanding margins, with major acquisitions poised to reshape its long-term profile.
Vital Farms shares have tumbled over 35% in the past year, lagging the broader market. A deep dive into valuation metrics, including DCF analysis and P/E comparisons, suggests the stock may be significantly undervalued. But is the market missing something?
